COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed

Author(s): Mercedes Jimenez*, Nuria E. Campillo*, Matilde Canelles

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 20 , 2021


  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the disease termed COVID-19 that has caused millions of infections worldwide. In this article, we have analyzed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. From our analysis, it becomes clear that there is a big difference in the immune response against SARS in children, young adults and the elderly, both at the innate and adaptive levels. Taking this information into account, we have studied the strategies that are being used for the development of COVID-19 vaccines. We discussed the perspectives for obtention and worldwide distribution of reliable vaccines using this perspective. The conclusion is that different vaccines may be protective for different age segments within the population, depending on the strategy used for their design. Therefore, it will become necessary for several vaccines to reach the finish line, not only to ensure availability, but also to guarantee an adequate immune response at the individual level.

Keywords: COVID-19, SARS-CoV-2, infection, coronavirus immune response, vaccine development, vaccine phases.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 28
ISSUE: 20
Year: 2021
Published on: 27 October, 2020
Page: [3964 - 3979]
Pages: 16
DOI: 10.2174/0929867327666201027153123
Price: $65

Article Metrics

PDF: 224